These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
173 related items for PubMed ID: 3133194
1. Bone mineral metabolism in experimental diabetes mellitus: osteocalcin as a measure of bone remodeling. Glajchen N, Epstein S, Ismail F, Thomas S, Fallon M, Chakrabarti S. Endocrinology; 1988 Jul; 123(1):290-5. PubMed ID: 3133194 [Abstract] [Full Text] [Related]
2. Effect of cyclosporin A on bone mineral metabolism in experimental diabetes mellitus in the rat. Epstein S, Takizawa M, Stein B, Katz IA, Joffe II, Romero DF, Liang XG, Li M, Ke HZ, Jee WS. J Bone Miner Res; 1994 Apr; 9(4):557-66. PubMed ID: 8030444 [Abstract] [Full Text] [Related]
3. The bisphosphonate 2-PEBP inhibits cyclosporin A induced high-turnover osteopenia in the rat. Movsowitz C, Epstein S, Fallon M, Ismail F, Thomas S. J Lab Clin Med; 1990 Jan; 115(1):62-8. PubMed ID: 2299257 [Abstract] [Full Text] [Related]
7. Cyclosporin A in the oophorectomized rat: unexpected severe bone resorption. Movsowitz C, Epstein S, Ismail F, Fallon M, Thomas S. J Bone Miner Res; 1989 Jun; 4(3):393-8. PubMed ID: 2788358 [Abstract] [Full Text] [Related]
8. The effect of chronic caffeine administration on serum markers of bone mineral metabolism and bone histomorphometry in the rat. Glajchen N, Ismail F, Epstein S, Jowell PS, Fallon M. Calcif Tissue Int; 1988 Nov; 43(5):277-80. PubMed ID: 3145792 [Abstract] [Full Text] [Related]
10. Circulating levels and bone contents of bone gamma-carboxyglutamic acid-containing protein are decreased in streptozocin-induced diabetes. Possible marker for diabetic osteopenia. Ishida H, Seino Y, Taminato T, Usami M, Takeshita N, Seino Y, Tsutsumi C, Moriuchi S, Akiyama Y, Hara K. Diabetes; 1988 Jun; 37(6):702-6. PubMed ID: 3260200 [Abstract] [Full Text] [Related]
11. Increased nerve polyol levels in experimental diabetes and their reversal by Sorbinil. Whiting PH, Ross IS. Br J Exp Pathol; 1988 Oct; 69(5):697-702. PubMed ID: 3143396 [Abstract] [Full Text] [Related]
14. Cyclosporin-A in vivo produces severe osteopenia in the rat: effect of dose and duration of administration. Movsowitz C, Epstein S, Fallon M, Ismail F, Thomas S. Endocrinology; 1988 Nov; 123(5):2571-7. PubMed ID: 3262506 [Abstract] [Full Text] [Related]
16. Effect of the interaction of parathyroid hormone and cyclosporine a on bone mineral metabolism in the rat. Epstein S, Dissanayake IR, Goodman GR, Bowman AR, Zhou H, Ma Y, Jee WS. Calcif Tissue Int; 2001 Apr; 68(4):240-7. PubMed ID: 11353952 [Abstract] [Full Text] [Related]
18. Evaluation of an aldose reductase inhibitor on lens metabolism, ATPases and antioxidative defense in streptozotocin-diabetic rats: an intervention study. Obrosova IG, Fathallah L. Diabetologia; 2000 Aug; 43(8):1048-55. PubMed ID: 10990083 [Abstract] [Full Text] [Related]
19. Sorbinil prevents glomerular hyperperfusion in diabetic rats. Bank N, Mower P, Aynedjian HS, Wilkes BM, Silverman S. Am J Physiol; 1989 Jun; 256(6 Pt 2):F1000-6. PubMed ID: 2500028 [Abstract] [Full Text] [Related]
20. The effects of streptozotocin-induced diabetes and aldose reductase inhibition with sorbinil, on left and right atrial function in the rat. Sellers DJ, Chess-Williams R. J Pharm Pharmacol; 2000 Jun; 52(6):687-94. PubMed ID: 10875546 [Abstract] [Full Text] [Related] Page: [Next] [New Search]